Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LifeMD, Inc. stock logo
LFMD
LifeMD
$12.72
+5.3%
$8.11
$3.99
$13.25
$578.10M2.421.01 million shs1.77 million shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$5.84
-1.5%
$6.24
$4.64
$8.61
$2.27B1.221.60 million shs923,460 shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$27.46
+1.8%
$29.62
$19.73
$47.32
$2.15B2.14907,705 shs996,187 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$72.07
+4.2%
$79.88
$24.29
$117.75
$2.06B1.94773,760 shs567,660 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LifeMD, Inc. stock logo
LFMD
LifeMD
+5.30%+4.69%+58.31%+172.38%+54.74%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-1.52%-1.85%+5.99%-23.06%+1.57%
Veracyte, Inc. stock logo
VCYT
Veracyte
+1.78%+2.12%-10.84%-14.24%+25.91%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
+4.18%+1.92%+25.69%-26.47%+164.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LifeMD, Inc. stock logo
LFMD
LifeMD
1.5908 of 5 stars
1.54.00.00.03.91.70.6
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.5422 of 5 stars
3.41.00.00.03.72.50.6
Veracyte, Inc. stock logo
VCYT
Veracyte
4.4045 of 5 stars
4.43.00.04.33.20.00.6
GeneDx Holdings Corp. stock logo
WGS
GeneDx
3.5208 of 5 stars
2.43.00.00.03.55.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$11.00-13.52% Downside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.83
Moderate Buy$8.5045.55% Upside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.70
Moderate Buy$40.9048.94% Upside
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.75
Moderate Buy$86.7520.37% Upside

Current Analyst Ratings Breakdown

Latest LFMD, LFST, WGS, and VCYT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$8.50
5/15/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
5/9/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$80.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$49.00 ➝ $42.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$51.00 ➝ $41.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$135.00 ➝ $110.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.00
4/30/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00
4/9/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$45.00 ➝ $37.00
4/8/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$9.00
4/7/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LifeMD, Inc. stock logo
LFMD
LifeMD
$234.01M2.47N/AN/A$0.15 per share84.80
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.28B1.77N/AN/A$3.77 per share1.55
Veracyte, Inc. stock logo
VCYT
Veracyte
$463.39M4.64$0.06 per share442.29$14.30 per share1.92
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$330.14M6.23N/AN/A$8.78 per share8.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LifeMD, Inc. stock logo
LFMD
LifeMD
-$20.60M-$0.34N/A106.00N/A-12.06%N/A-36.34%8/6/2025 (Estimated)
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$186.26M-$0.10N/AN/AN/A-7.90%-6.66%-4.51%8/14/2025 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
-$74.40M$0.41N/A38.14N/A-2.18%3.02%2.80%8/5/2025 (Estimated)
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$175.77M-$1.41N/A34.48N/A-17.12%3.33%1.69%7/29/2025 (Estimated)

Latest LFMD, LFST, WGS, and VCYT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.04$0.01+$0.05$0.01$62.47 million$65.70 million
4/30/2025Q1 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million
3/10/2025Q4 2024
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.04-$0.02+$0.02-$0.02$57.43 million$64.26 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
0.83
0.78
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.19
1.32
1.32
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
5.08
4.79
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.25
2.40
2.27

Institutional Ownership

CompanyInstitutional Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.20%
Veracyte, Inc. stock logo
VCYT
Veracyte
1.40%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23045.45 million36.40 millionOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
6,640388.88 million357.39 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
79078.32 million76.49 millionOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,20028.53 million19.97 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LifeMD stock logo

LifeMD NASDAQ:LFMD

$12.72 +0.64 (+5.30%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$12.77 +0.05 (+0.39%)
As of 06/6/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$5.84 -0.09 (-1.52%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$5.84 +0.00 (+0.09%)
As of 06/6/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Veracyte stock logo

Veracyte NASDAQ:VCYT

$27.46 +0.48 (+1.78%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$27.82 +0.36 (+1.33%)
As of 06/6/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

GeneDx stock logo

GeneDx NASDAQ:WGS

$72.07 +2.90 (+4.19%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$69.48 -2.59 (-3.60%)
As of 06/6/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.